Liver Diseases Therapeutics Market Report 2026
Download Free Sample Buy Now
Liver Diseases Therapeutics Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Liver Diseases Therapeutics Market Report 2026

Global Outlook – By Disease Type (Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment (Antiviral, Chemotherapy, Immunosuppressive Agents, Corticosteroids ), By End User (Hospitals, Ambulatory Surgery Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Liver Diseases Therapeutics Market Overview

• Liver Diseases Therapeutics market size has reached to $15.18 billion in 2025

• Expected to grow to $24.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%

• Growth Driver: Elevating Prevalence Of Liver Diseases Fuels Growth In Liver Disease Therapeutics Market

• Market Trend: Revolutionizing Liver Disease Therapeutics With Ai-Powered Technology

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Liver Diseases Therapeutics Market?

Liver disease therapeutics refers to the treatment of numerous types of liver illnesses, diseases brought on by viruses, including hepatitis A, B, and C. Liver disease therapeutics are essential for enhancing the quality of life for those impacted by liver conditions and alleviating the overall strain of liver disease on healthcare systems.

The main disease types of liver disease therapeutics are hepatitis, non-alcoholic fatty liver disease, alcohol-induced, and liver cancer. Hepatitis refers to an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents leading to a range of health problems, some of which can be fatal. The treatment is antiviral, vaccines, chemotherapy, immunosuppressive agents, and corticosteroids. The end-users included hospitals, ambulatory surgery centers, and other end-users.

Liver Diseases Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Liver Diseases Therapeutics Market Size and Share 2026?

The liver diseases therapeutics market size has grown strongly in recent years. It will grow from $15.18 billion in 2025 to $16.66 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to high prevalence of viral hepatitis infections, increasing alcohol-induced liver disease cases, early reliance on antiviral and supportive therapies, limited treatment options for chronic liver conditions, growing hospital-based liver care.

What Is The Liver Diseases Therapeutics Market Growth Forecast?

The liver diseases therapeutics market size is expected to see strong growth in the next few years. It will grow to $24.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to rising burden of metabolic liver diseases, increasing adoption of immunosuppressive and targeted therapies, expanding liver cancer treatment pipelines, growing awareness of early treatment benefits, higher healthcare spending on chronic liver diseases. Major trends in the forecast period include rising demand for antiviral therapies in hepatitis treatment, growing focus on nafld and nash management, increasing adoption of immunotherapy in liver cancer, expansion of combination drug therapies, rising emphasis on long-term disease management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Liver Diseases Therapeutics Market Segmentation

1) By Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer

2) By Treatment: Antiviral, Chemotherapy, Immunosuppressive Agents, Corticosteroids

3) By End User: Hospitals, Ambulatory Surgery Centers

Subsegments:

1) By Hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D

2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH), Simple Fatty Liver

3) By Alcohol-Induced: Alcoholic Hepatitis, Alcoholic Cirrhosis

4) By Liver Cancer: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma

What Is The Driver Of The Liver Diseases Therapeutics Market?

The rising prevalence of liver diseases is expected to propel the growth of the liver disease therapeutics market going forward. Liver disease refers to any condition that has been affecting the liver. Liver disease therapeutics help in treating liver diseases through various treatments. For instance, in December 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, reported that in 2023, the number of premature deaths from alcoholic liver disease increased by 3.6%, reaching 5,984, up from 5,776 in 2022. Therefore, the rising prevalence of liver diseases drives the growth of the liver disease therapeutics market.

Key Players In The Global Liver Diseases Therapeutics Market

Major companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Gilead Sciences Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.

Global Liver Diseases Therapeutics Market Trends and Insights

Major companies operating in the liver disease therapeutics market are focusing on innovative technologies, such as artificial intelligence, to help clinicians identify patients with liver fibrosis early in their disease progression. Artificial intelligence in liver disease therapeutics refers to the application of advanced computational algorithms and machine learning techniques to analyze medical data, aiding in early detection, diagnosis, and personalized treatment strategies for liver diseases. For instance, in February 2023, Predictive Health Intelligence, a UK-based healthcare information management company, launched the hepatoSIGHT. hepatoSIGHT, an innovative AI-powered tool that can predict liver fibrosis in patients with chronic liver disease. It is a case-finding and cohort mapping tool designed to identify patients at risk of chronic liver disease (CLD). It is a secure, intuitive, and easy-to-use system that can review millions of lines of data within seconds to identify patients who meet specified criteria. Moreover, it has features such as comprehensive data analysis, machine learning algorithms, real-time risk stratification, and an easy-to-use interface.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Liver Diseases Therapeutics Market?

In September 2025, Bausch Health Companies Inc., a Canada-based pharmaceutical/healthcare company, acquired DURECT Corporation for an undisclosed amount. With this acquisition, Bausch Health aimed to strengthen and accelerate its hepatology pipeline by adding an advanced-stage therapy for alcohol-associated hepatitis and expand its late-stage liver-disease R&D capabilities. DURECT Corporation is a US-based late-stage biopharmaceutical company that specializes in developing epigenetic therapies that target dysregulated DNA methylation, with its lead asset larsucosterol in clinical development for alcohol-associated hepatitis.

Regional Outlook

North America was the largest region in the liver diseases therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Liver Diseases Therapeutics Market?

The liver diseases therapeutics market includes revenues earned by entities by diagnosis such as imaging, laboratory tests, endoscopy, and biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Liver Diseases Therapeutics Market Report 2026?

The liver diseases therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the liver diseases therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Liver Diseases Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $16.66 billion
Revenue Forecast In 2035 $24.27 billion
Growth Rate CAGR of 9.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Disease Type, Treatment, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Gilead Sciences Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Liver Diseases Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Liver Diseases Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Liver Diseases Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Liver Diseases Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Demand For Antiviral Therapies In Hepatitis Treatment

4.2.2 Growing Focus On Nafld And Nash Management

4.2.3 Increasing Adoption Of Immunotherapy In Liver Cancer

4.2.4 Expansion Of Combination Drug Therapies

4.2.5 Rising Emphasis On Long-Term Disease Management

5. Liver Diseases Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ambulatory Surgery Centers

5.3 Specialty Liver Clinics

5.4 Cancer Treatment Centers

5.5 Hepatology Care Centers

6. Liver Diseases Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Liver Diseases Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Liver Diseases Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Liver Diseases Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Liver Diseases Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Liver Diseases Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Liver Diseases Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Liver Diseases Therapeutics Market Segmentation

9.1. Global Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer

9.2. Global Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antiviral, Chemotherapy, Immunosuppressive Agents, Corticosteroids

9.3. Global Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ambulatory Surgery Centers, Specialty Liver Clinics

9.4. Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Hepatitis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D

9.5. Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Non-Alcoholic Fatty Liver Disease (NAFLD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Alcoholic Steatohepatitis (NASH), Simple Fatty Liver

9.6. Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Alcohol-Induced Liver Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alcoholic Hepatitis, Alcoholic Cirrhosis

9.7. Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatocellular Carcinoma (HCC), Cholangiocarcinoma

10. Liver Diseases Therapeutics Market Regional And Country Analysis

10.1. Global Liver Diseases Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Liver Diseases Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Liver Diseases Therapeutics Market

11.1. Asia-Pacific Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Liver Diseases Therapeutics Market

12.1. China Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Liver Diseases Therapeutics Market

13.1. India Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Liver Diseases Therapeutics Market

14.1. Japan Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Liver Diseases Therapeutics Market

15.1. Australia Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Liver Diseases Therapeutics Market

16.1. Indonesia Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Liver Diseases Therapeutics Market

17.1. South Korea Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Liver Diseases Therapeutics Market

18.1. Taiwan Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Liver Diseases Therapeutics Market

19.1. South East Asia Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Liver Diseases Therapeutics Market

20.1. Western Europe Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Liver Diseases Therapeutics Market

21.1. UK Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Liver Diseases Therapeutics Market

22.1. Germany Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Liver Diseases Therapeutics Market

23.1. France Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Liver Diseases Therapeutics Market

24.1. Italy Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Liver Diseases Therapeutics Market

25.1. Spain Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Liver Diseases Therapeutics Market

26.1. Eastern Europe Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Liver Diseases Therapeutics Market

27.1. Russia Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Liver Diseases Therapeutics Market

28.1. North America Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Liver Diseases Therapeutics Market

29.1. USA Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Liver Diseases Therapeutics Market

30.1. Canada Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Liver Diseases Therapeutics Market

31.1. South America Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Liver Diseases Therapeutics Market

32.1. Brazil Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Liver Diseases Therapeutics Market

33.1. Middle East Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Liver Diseases Therapeutics Market

34.1. Africa Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Liver Diseases Therapeutics Market, Segmentation By Disease Type, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Liver Diseases Therapeutics Market Regulatory and Investment Landscape

36. Liver Diseases Therapeutics Market Competitive Landscape And Company Profiles

36.1. Liver Diseases Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Liver Diseases Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Liver Diseases Therapeutics Market Company Profiles

36.3.1. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Liver Diseases Therapeutics Market Other Major And Innovative Companies

GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Gilead Sciences Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc.

38. Global Liver Diseases Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Liver Diseases Therapeutics Market

40. Liver Diseases Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Liver Diseases Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Liver Diseases Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Liver Diseases Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Liver Diseases Therapeutics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Liver Diseases Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Liver Diseases Therapeutics Market, Supply Chain Analysis
  • Table 4: Global Liver Diseases Therapeutics Market, Major Raw Material Providers
  • Table 5: Global Liver Diseases Therapeutics Market, Major Resource Providers
  • Table 6: Global Liver Diseases Therapeutics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Liver Diseases Therapeutics Market, Major Distributors And Channel Partners
  • Table 8: Global Liver Diseases Therapeutics Market, Key Technologies & Future Trends
  • Table 9: Global Liver Diseases Therapeutics Market, Major Trends
  • Table 10: Global Liver Diseases Therapeutics Market, Major End Users
  • Table 11: Global Liver Diseases Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Liver Diseases Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Liver Diseases Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Liver Diseases Therapeutics Market - TAM, US$ Billion, 2025
  • Table 15: Global Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Hepatitis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Non-Alcoholic Fatty Liver Disease (NAFLD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Alcohol-Induced Liver Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Liver Diseases Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Liver Diseases Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Liver Diseases Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Liver Diseases Therapeutics Market - Company Scoring Matrix
  • Table 98: Astellas Pharma Inc. Financial Performance
  • Table 99: Bristol-Myers Squibb Company Financial Performance
  • Table 100: F. Hoffmann-La Roche AG Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: Novartis AG Financial Performance
  • Table 103: Global Liver Diseases Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Liver Diseases Therapeutics Market, Competitive Dashboard
  • Table 105: Global Liver Diseases Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Table 107: Global, Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 108: Global, Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Liver Diseases Therapeutics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Liver Diseases Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Liver Diseases Therapeutics Market, Supply Chain Analysis
  • Figure 4: Global Liver Diseases Therapeutics Market, Major Raw Material Providers
  • Figure 5: Global Liver Diseases Therapeutics Market, Major Resource Providers
  • Figure 6: Global Liver Diseases Therapeutics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Liver Diseases Therapeutics Market, Major Distributors And Channel Partners
  • Figure 8: Global Liver Diseases Therapeutics Market, Key Technologies & Future Trends
  • Figure 9: Global Liver Diseases Therapeutics Market, Major Trends
  • Figure 10: Global Liver Diseases Therapeutics Market, Major End Users
  • Figure 11: Global Liver Diseases Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Liver Diseases Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Liver Diseases Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Liver Diseases Therapeutics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Hepatitis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Non-Alcoholic Fatty Liver Disease (NAFLD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Alcohol-Induced Liver Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Liver Diseases Therapeutics Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Liver Diseases Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Liver Diseases Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Liver Diseases Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Liver Diseases Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Liver Diseases Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Liver Diseases Therapeutics Market - Company Scoring Matrix
  • Figure 98: Astellas Pharma Inc. Financial Performance
  • Figure 99: Bristol-Myers Squibb Company Financial Performance
  • Figure 100: F. Hoffmann-La Roche AG Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: Novartis AG Financial Performance
  • Figure 103: Global Liver Diseases Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Liver Diseases Therapeutics Market, Competitive Dashboard
  • Figure 105: Global Liver Diseases Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Figure 107: Global, Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 108: Global, Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Digital Diagnostics Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Read More About Digital Diagnostics Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Digital Healthcare Supply Chain Management Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Digital Healthcare Supply Chain Management Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Digital Healthcare Supply Chain Management Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Digital Healthcare Supply Chain Management Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Direct To Consumer Testing Market Projected to Reach $3.94 Billion by 2029 at a CAGR of 15%

Read More About Global Direct To Consumer Testing Market Projected to Reach $3.94 Billion by 2029 at a CAGR of 15%

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Ultrasonic Technology Market 2023 – By Type (Ultrasonic Proximity Sensor, Ultrasonic Retro-Reflective Sensor, Ultrasonic Through-Beam Sensor, Other Types), By Technology (Ultrasonic Medical Technology, Ultrasonic Process...

Microcarrier Market Report 2026 - Global Outlook – By Product (Equipment, Consumables), By Microcarrier Type (Cationic Microcarriers, Collagen-Coated Microcarriers, Protein-Coated Microcarriers, Untreated Microcarriers, ...

Lagers Market Report 2026 - Global Outlook – By Product Type (Standard Lager, Premium Lager, Luxury Lager), By Variety (Pale Lager, Vienna Lager, Dark Lager), By Packaging Type (Glass, Metal Can, Other Packaging Types), ...

Debt Financing Market Report 2026 - Global Outlook – By Sources (Private, Public), By Type (Bank Loans, Bonds, Debentures, Other Types), By Duration (Short-Term, Long-Term) – Market Size, Trends, Strategies, and Forecast...

Bone Densitometer Market Report 2026 - Global Outlook – By Type (DXA Systems, Peripheral Bone Densitometers, Radiographic Absorptiometry Scanners, Quantitative Ultrasound Scanners), By Application (Osteoporosis & Osteope...

Bio-Based Propylene Glycol Market Report 2026 - Global Outlook – By Type (Bio-Based 1, 2- Propylene Glycol, Bio-Based 1,3- Propylene Glycol), By Application (Solvent, Chemical Intermediates, Unsaturated Polyester Adhesiv...

Plasma Feed Market Report 2026 - Global Outlook – By Source (Porcine, Bovine, Other Sources), By Sales Channel (Online, Offline), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications) – Market Size, Trends,...

Frequently Asked Questions

The Liver Diseases Therapeutics market was valued at $15.18 billion in 2025, increased to $16.66 billion in 2026, and is projected to reach $24.27 billion by 2030.

The global Liver Diseases Therapeutics market is expected to grow at a CAGR of 9.9% from 2026 to 2035 to reach $24.27 billion by 2035.

Some Key Players in the Liver Diseases Therapeutics market Include, Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, John

Major trend in this market includes: Revolutionizing Liver Disease Therapeutics With Ai-Powered Technology. For further insights on this market. request a sample here

North America was the largest region in the liver diseases therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covere

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us